Average Co-Inventor Count = 2.65
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim Pharmaceuticals, Inc. (16 from 276 patents)
2. Inhibikase Therapeutics, Inc. (7 from 9 patents)
3. Allocyte Pharmaceuticals Ag (1 from 1 patent)
4. Cytosite Biopharma Inc. (1 from 1 patent)
25 patents:
1. 11725005 - Compositions and methods for inhibiting kinases
2. 11667645 - Granzyme B directed imaging and therapy
3. 11407747 - Compositions and methods for inhibiting kinases
4. 10906896 - Compositions and methods for inhibiting kinases
5. 10344027 - Compositions and methods for inhibiting kinases
6. 10316031 - Compositions and methods for inhibiting kinases
7. 10118923 - Compositions and methods for inhibiting kinases
8. 10077238 - Small molecule LFA-1 inhibitors
9. 9828370 - Compositions and methods for inhibiting kinases
10. 7589115 - [object Object]
11. 7550494 - Small molecules useful in the treatment of inflammatory disease
12. 7462637 - [object Object]
13. 7345074 - Derivatives of [6,7-dihydro-5H-imidazol[1,2-a]imidazole-3-sulfonylamino]-propionamide
14. 7304067 - Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
15. 6852748 - Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide